- Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon
- Author: Mr Mfazo Hove
- Published: October 8, 2024
- Last Updated: August 25, 2026
TL;DR: Is Private Cataract Surgery Worth It?
For many people, yes, private cataract surgery can be worth paying for.
But I do not say that because NHS cataract surgery is poor. It is not. Excellent cataract surgery is performed throughout the NHS every day.
The principal reason to go private is choice and control.
You can choose your surgeon. You can usually choose when you have surgery. You can explore a much broader range of intraocular lenses. You can decide how important freedom from glasses is to you. And your treatment can be planned around the type of vision you want after surgery rather than focusing solely on removing the cataract. That whole approach, including what happens if your result ever needs fine-tuning, is set out in the Blue Fin Vision® Advantage and its Enhancement Policy.
Having performed more than 57,000 procedures, and having subsequently experienced intraocular lens surgery myself, my view is that the question is not simply:
“Is private cataract surgery better?”
A much better question is:
“What am I getting by going private, and are those differences important enough to me to justify the cost?”
For many patients, they are.
Cataract Surgery Is No Longer Just About Removing a Cataract
A cataract is the progressive clouding of the natural lens inside the eye. Cataract surgery removes that cloudy lens and replaces it with a clear artificial intraocular lens, or IOL.
The benefits of cataract surgery itself are extremely well established.
Peter Desai, Anne Reidy, Darwin Minassian, George Vafidis and John Bolger studied patients after cataract surgery and demonstrated meaningful improvements not only in measured vision but also in patients’ visual functioning and quality of life. ¹
Modern cataract surgery, however, offers something that was far less prominent when I began my ophthalmic career.
It is also a refractive procedure.
When I remove your natural lens, I have to replace it with another lens. That replacement lens will affect the way you see for potentially the rest of your life.
That makes lens selection one of the most important decisions surrounding cataract surgery.
Why Do Patients Choose Private Cataract Surgery?
In my experience, there are several reasons, but the most important are speed, choice of surgeon, continuity of care and access to a wider range of lens technologies.
1. You Can Usually Have Surgery Sooner
Once a cataract is affecting your driving, reading, work, hobbies or independence, waiting for surgery is not necessarily inconsequential.
One particularly interesting randomised controlled trial involved 306 women aged over 70. Rowan Harwood, Andrew Foss, Fiona Osborn, Robert Gregson, A Zaman and Tahir Masud compared expedited cataract surgery with routine waiting. Surgery improved visual function and was associated with a 34% reduction in the rate of falls in the group offered expedited first-eye surgery. ²
That does not mean everyone with a cataract requires immediate surgery.
It does mean that once vision is materially interfering with someone’s life, months spent waiting are still months spent living with impaired vision.
At Blue Fin Vision®, private cataract treatment can usually be arranged substantially more quickly than a routine NHS pathway.
For someone who is struggling to drive confidently, work effectively or enjoy normal activities, that may itself make private treatment worthwhile.
2. You Can Choose the Surgeon Who Will Actually Operate on Your Eyes
For me, this is one of the strongest arguments for private cataract surgery.
Private treatment gives you the opportunity to research the individual surgeon who will perform your operation.
You can look at their training, surgical experience, subspecialist expertise, published outcomes and approach to complications.
You can also ask a very simple question:
Will the consultant I meet before surgery be the surgeon who actually performs my operation?
At Blue Fin Vision®, cataract surgery is consultant-delivered. The consultant is responsible for assessment, surgical planning and the operation itself.
I have now performed more than 57,000 ophthalmic procedures.
That figure is not presented because volume somehow makes surgery risk-free. No responsible surgeon should ever promise that.
What very high surgical volume provides is experience.
It means having operated on an enormous range of eyes: straightforward cataracts, complex cataracts, small pupils, dense lenses, unusual anatomy, astigmatism, previous surgery and patients with very different visual requirements.
When somebody is paying privately for surgery on their eyes, I think it is entirely reasonable for them to investigate the experience of the person who will actually hold the instruments.
3. Private Surgery Gives You Much Greater Choice Over Your Lens
This is where private cataract surgery can become fundamentally different from a standard cataract pathway.
A conventional monofocal intraocular lens can provide exceptionally good quality vision. For many patients, it is exactly the right lens.
But it usually places the emphasis on one principal focal distance, which means glasses may still be required for other distances.
Private cataract surgery can allow suitable patients to consider a broader range of options, including premium monofocal, toric and presbyopia-correcting intraocular lenses. Our IOL lens guide sets out the categories in more detail.
This matters because two patients with exactly the same cataract may want completely different things from their surgery.
One may tell me:
“I don’t mind wearing reading glasses. I want the best possible distance quality.”
Another may say:
“I have worn glasses all my life. If my eyes are suitable, I want as much freedom from them as possible.”
Neither is wrong.
The operation should be designed around the patient rather than forcing every patient into the same visual solution.
My Perspective Is Different Because I Have Trifocal Lenses in My Own Eyes
This part of the discussion is not theoretical for me.
I spent more than two years of my career at Moorfields researching multifocal intraocular lenses and their visual outcomes. Years later, I chose to have trifocal intraocular lenses implanted in both of my own eyes. I therefore live every day with the same category of premium lens technology that I once studied academically and now discuss with patients.
My experience has reinforced my belief that advanced lenses can be extraordinary, but they have to be put into the right eyes and, equally importantly, into the right patient.
My trifocal lenses give me a continuous functional range of vision from near through intermediate to distance. My distance vision is excellent and I am highly independent of glasses.
Glare and haloes are real. In my case they are very tolerable.
I also notice something that is often overlooked when patients concentrate exclusively on the type of lens: the ocular surface can have an enormous effect on perceived quality of vision. My vision can be slightly blurred immediately on waking when my eyes are dry and then clear within minutes as the ocular surface recovers.
Living with premium lenses has therefore made me more, rather than less, selective about recommending them.
The most expensive or technologically sophisticated lens is not automatically the best lens for every patient.
What Does the Evidence Say About Multifocal Lenses?
Premium lens technology is not simply marketing.
In a randomised European clinical trial involving patients undergoing bilateral cataract surgery, Sunil Shah, Cristina Peris-Martinez, Thomas Reinhard and Paolo Vinciguerra compared multifocal and monofocal intraocular lenses. At six months, 73.3% of patients in the multifocal group were spectacle independent compared with 25.3% in the monofocal group. ³
Another important randomised trial conducted through Moorfields compared bilateral multifocal lenses with monofocal lenses targeted for monovision. Mark Wilkins, Bruce Allan, Gary Rubin, Oliver Findl, Emma Hollick, Catey Bunce and Wen Xing found that 71.3% of multifocal patients reported never wearing glasses compared with 25.8% of the monovision group. ⁴
But that same study illustrates why informed consent matters.
Six patients in the multifocal arm underwent an IOL exchange during the first postoperative year, while none did in the monovision group. ⁴
That is precisely the conversation patients need to have.
Multifocal and trifocal technology can offer remarkable spectacle independence, but these lenses deliberately manipulate the way light is distributed through the optical system. Dysphotopsias such as glare and haloes can occur.
The goal is therefore not to persuade everybody to have a trifocal.
It is to identify the patient for whom the benefits are likely to outweigh the compromises.
Lens Choice Should Be a Medical Decision, Not an Upgrade Menu
I do not believe cataract patients should simply be shown a series of lenses labelled “good, better and best”.
That is not how eyes work.
Before recommending a lens I need to consider the health of the cornea, ocular surface, macula, retina and optic nerve; the amount and type of astigmatism; previous eye surgery; pupil behaviour; refractive measurements; and what the patient actually expects to do without glasses.
Lifestyle matters too.
A professional driver who spends hours travelling at night may have different priorities from someone whose overwhelming priority is reading without spectacles.
A patient who will be extremely troubled by any halo may make a different choice from somebody who considers a degree of halo an acceptable trade-off for greater spectacle independence.
My own experience with trifocal lenses allows me to explain those compromises from both sides of the consultation desk.
4. Private Cataract Surgery Lets You Decide What You Want Your Vision to Be Like Afterwards
This is perhaps the most important conceptual change in modern cataract surgery.
The endpoint should not simply be:
“The cataract has gone.”
We should also be asking:
“What do we want the patient to see?”
Distance vision? Computer distance? Reading? Freedom from glasses? Correction of astigmatism? Excellent night-time optical quality?
Some of these aims can be combined. Others require compromises.
Good refractive cataract surgery is about understanding those trade-offs before the operation rather than discovering them afterwards.
5. More Technology Does Not Automatically Mean Better Surgery
Private providers sometimes advertise particular technologies as though the presence of a machine automatically guarantees better cataract surgery.
The evidence does not support such a simplistic conclusion.
A major UK randomised controlled trial, the FACT trial, compared femtosecond laser-assisted cataract surgery with conventional phacoemulsification.
Alexander Day, Jennifer Burr, Kate Bennett, Catey Bunce, Caroline Doré, Gary Rubin, Mayank Nanavaty, Kamaljit Balaggan and Mark Wilkins found that both techniques produced very good outcomes, with femtosecond surgery not providing superior patient-reported or visual outcomes. ⁵
Technology can be useful.
But I would not choose a cataract surgeon simply because they have a particular machine.
The surgeon, assessment, biometry, lens selection, surgical execution and aftercare matter more than the marketing label attached to a piece of equipment.
Is Private Cataract Surgery Safer Than NHS Cataract Surgery?
Not automatically.
I would not tell a patient that an operation is inherently safer simply because they have paid privately for it.
Both private and NHS cataract surgery can achieve excellent outcomes.
What matters is how surgery is performed, who performs it, the systems surrounding the surgeon, appropriate patient selection, infection prevention and the ability to recognise and manage complications.
For example, one of the most influential cataract-surgery safety studies was the European Society of Cataract & Refractive Surgeons’ prospective randomised multicentre trial involving more than 16,000 patients.
The Endophthalmitis Study Group of the European Society of Cataract & Refractive Surgeons found that omission of intracameral cefuroxime was associated with almost a five-fold increase in postoperative endophthalmitis risk. ⁶
That is genuine evidence-based safety.
The meaningful questions for a private patient are therefore not whether the building looks luxurious.
They are: Who is operating? What are their outcomes? What infection-control measures are used? What happens if there is a complication? Who sees me afterwards? And is there a system capable of dealing with an unexpected problem?
Since I have just told you to ask any prospective surgeon about their outcomes, it is only fair that I answer the question myself.
The Royal College of Ophthalmologists’ National Ophthalmology Database (NOD) audit provides the UK’s national benchmark for cataract surgery outcomes. Posterior capsule rupture is one of its principal measures of surgical safety. ⁷ The latest national audit reports a PCR rate of 0.69% across participating cataract surgery providers. ⁸
I publish my own audited outcomes against that national benchmark, with six consecutive years of NOD data released as full datasets. My posterior capsule rupture rate runs at approximately 0.2%, substantially below the current national rate of 0.69%. In the rare event of a complication such as a dropped lens fragment, it is managed within our own vitreoretinal service, with no additional surgical fee.
Openly published, independently benchmarked outcomes are, in my view, a far better basis for choosing a surgeon than any brochure.
What Are You Actually Paying for Privately?
This is where I think the decision becomes much clearer.
You are not paying simply to have a cataract removed.
You are potentially paying for control over the entire pathway.
You are paying for the ability to choose an experienced consultant surgeon, obtain treatment promptly, undertake detailed diagnostic assessment, explore premium lens technology, choose your intended refractive outcome and have greater continuity before and after surgery.
You are also paying for what happens after surgery if the result is not quite perfect.
Modern lens surgery is highly accurate, but across all providers a small percentage of patients may benefit from a secondary refinement to optimise the final prescription. What varies enormously between providers is who pays for that refinement.
Under the Blue Fin Vision® Enhancement Policy, which forms part of the Blue Fin Vision® Advantage, enhancement for self-pay and premium lens patients is fully covered within 24 months of the original procedure, with no cost-sharing and no hidden top-up charge.
For insured cataract surgery with a standard monofocal lens, where the clinical objective is restoring functional vision rather than spectacle independence, enhancement is not included. You will know that before treatment begins, not after.
The full detail is set out in What Is Enhancement After Cataract Surgery?.
I regard that as part of the same principle as publishing outcomes: you should know exactly where you stand before you commit, not discover it afterwards.
At the time of this update, private cataract surgery at Blue Fin Vision® starts from £4,000 per eye, with premium monofocal, toric and trifocal options priced according to lens type, and a consultation fee of £325. The live cataract surgery pricing page should always be checked for current prices and inclusions.
That is a significant amount of money.
The question therefore has to be whether the additional choice, control and cover have value to you.
When Might Private Cataract Surgery Not Be Worth It?
Private surgery is not automatically the correct decision.
If you are happy with your NHS pathway, your waiting time is acceptable, you are comfortable with the lens option available to you and paying privately would impose financial strain, there may be little reason to change.
The NHS is capable of delivering excellent cataract surgery.
That point matters because I do not believe patients make good decisions when they are frightened into them.
Private cataract surgery should justify its cost by offering something the individual patient genuinely values.
When Does Going Private Make the Most Sense?
Private surgery becomes particularly compelling when several factors come together.
You want to choose the individual surgeon performing your operation. You do not want to wait unnecessarily with deteriorating vision. You want detailed discussion of your refractive goals. You have astigmatism or are interested in premium lens technology. Reducing your dependence on spectacles is important to you. Or you place significant value on having a continuous consultant-led pathway with published outcomes and a written enhancement position.
In those circumstances, private cataract surgery is not simply the NHS operation performed in nicer surroundings.
It can be a different model of care.
So, Is It Worth Going Private for Cataract Surgery?
For many patients, yes.
But the strongest argument is not that private cataract surgery is automatically safer, and it is not that the NHS provides poor care.
The strongest argument is choice.
Having spent my professional career performing cataract and refractive surgery, having completed more than 57,000 ophthalmic procedures and having subsequently entrusted my own eyes to intraocular lens surgery, I have seen this decision from both sides.
When I chose trifocal lenses for my own eyes, I was not simply choosing to have my natural lenses removed.
I was deciding what I wanted my vision to be like afterwards.
That is exactly how I think patients should approach cataract surgery today.
For one person, an NHS operation with a monofocal lens may provide everything they want.
For another, being able to choose their surgeon, timing, lens technology and intended visual outcome, with published outcomes and a written enhancement policy behind the result, may be worth considerably more.
Private cataract surgery is therefore not necessarily about buying a “better cataract operation”. It is about buying greater control over one of the most consequential decisions you will ever make about your vision.
And for the right patient, that can be very worthwhile.
If you would like to explore what is possible for your own eyes, you can book a consultation with Blue Fin Vision®, a consultant-led UK clinic with documented outcomes and locations across London, Hertfordshire and Essex, including our flagship Harley Street clinic.
References
- Desai P, Reidy A, Minassian DC, Vafidis G, Bolger J. Gains from cataract surgery: visual function and quality of life. Br J Ophthalmol. 1996;80(10):868-873. doi:10.1136/bjo.80.10.868. PMID: 8976696.
- Harwood RH, Foss AJE, Osborn F, Gregson RM, Zaman A, Masud T. Falls and health status in elderly women following first eye cataract surgery: a randomised controlled trial. Br J Ophthalmol. 2005;89(1):53-59. doi:10.1136/bjo.2004.049478. PMID: 15615747.
- Shah S, Peris-Martinez C, Reinhard T, Vinciguerra P. Visual outcomes after cataract surgery: multifocal versus monofocal intraocular lenses. J Refract Surg. 2015;31(10):658-666. doi:10.3928/1081597X-20150611-01. PMID: 26465253.
- Wilkins MR, Allan BD, Rubin GS, Findl O, Hollick EJ, Bunce C, Xing W; Moorfields IOL Study Group. Randomized trial of multifocal intraocular lenses versus monovision after bilateral cataract surgery. Ophthalmology. 2013;120(12):2449-2455.e1. doi:10.1016/j.ophtha.2013.07.048. PMID: 24070808.
- Day AC, Burr JM, Bennett K, Bunce C, Doré CJ, Rubin GS, Nanavaty MA, Balaggan KS, Wilkins MR; FACT Group. Femtosecond laser-assisted cataract surgery versus phacoemulsification cataract surgery (FACT): a randomized noninferiority trial. Ophthalmology. 2020;127(8):1012-1019. doi:10.1016/j.ophtha.2020.02.028. PMID: 32386810.
- Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33(6):978-988. doi:10.1016/j.jcrs.2007.02.032. PMID: 17531690.
- Day AC, Donachie PHJ, Sparrow JM, Johnston RL. The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: report 1, visual outcomes and complications. Eye (Lond). 2015;29(4):552-560. doi:10.1038/eye.2015.3. PMID: 25679413.
- The Royal College of Ophthalmologists. National Ophthalmology Database Audit: Annual Report, cataract operations performed April 2023 to March 2024. London: RCOphth; 2025. Available from: https://www.nodaudit.org.uk/
ABOUT THE AUTHOR
Mr Mfazo Hove
Consultant Ophthalmic Surgeon
MBChB MD FRCOphth CertLRS
Mr Mfazo Hove is a Consultant Ophthalmic Surgeon with experience spanning more than 57,000 procedures. He completed 6.5 years of specialist training at Moorfields Eye Hospital and served for five years as a consultant at the Western Eye Hospital, Imperial College Healthcare NHS Trust. He is the founder of Blue Fin Vision®, a consultant-led private ophthalmology practice operating across London, Essex, and Hertfordshire. His clinical expertise encompasses advanced cataract surgery, refractive lens replacement, laser vision correction, and implantable Collamer lenses (ICL).
A ZEISS Key Opinion Leader, Mr Hove is a respected international speaker with five invited engagements across seven cities in 2026:
- ZEISS China tour (Changsha, Shanghai, and Hangzhou, April – ZEISS APAC User Meeting)
- RCOphth Annual Congress – May – Manchester
- ZEISS EMEA User Meeting (Istanbul)
- ZEISS Lausanne User Meeting (Lausanne)
- European Society of Cataract and Refractive Surgeons Annual Congress (ESCRS, London)
